Terms: = Lymphoma AND SRSF3, SRp20, SFRS3, 6428, ENSG00000112081, P84103
6 results:
1. Primary intracranial lymphomas-incidence and survival: a population-based study.
Jiang Y; Zheng X; Lu T; Gao P; Wang Y
Neurosurg Rev; 2023 Oct; 46(1):265. PubMed ID: 37804440
[TBL] [Abstract] [Full Text] [Related]
2. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
Dewaele M; Tabaglio T; Willekens K; Bezzi M; Teo SX; Low DH; Koh CM; Rambow F; Fiers M; Rogiers A; Radaelli E; Al-Haddawi M; Tan SY; Hermans E; Amant F; Yan H; Lakshmanan M; Koumar RC; Lim ST; Derheimer FA; Campbell RM; Bonday Z; Tergaonkar V; Shackleton M; Blattner C; Marine JC; Guccione E
J Clin Invest; 2016 Jan; 126(1):68-84. PubMed ID: 26595814
[TBL] [Abstract] [Full Text] [Related]
3. Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.
Sotillo E; Barrett DM; Black KL; Bagashev A; Oldridge D; Wu G; Sussman R; Lanauze C; Ruella M; Gazzara MR; Martinez NM; Harrington CT; Chung EY; Perazzelli J; Hofmann TJ; Maude SL; Raman P; Barrera A; Gill S; Lacey SF; Melenhorst JJ; Allman D; Jacoby E; Fry T; Mackall C; Barash Y; Lynch KW; Maris JM; Grupp SA; Thomas-Tikhonenko A
Cancer Discov; 2015 Dec; 5(12):1282-95. PubMed ID: 26516065
[TBL] [Abstract] [Full Text] [Related]
4. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Ringdén O; Brazauskas R; Wang Z; Ahmed I; Atsuta Y; Buchbinder D; Burns LJ; Cahn JY; Duncan C; Hale GA; Halter J; Hayashi RJ; Hsu JW; Jacobsohn DA; Kamble RT; Kamani NR; Kasow KA; Khera N; Lazarus HM; Loren AW; Marks DI; Myers KC; Ramanathan M; Saber W; Savani BN; Schouten HC; Socie G; Sorror ML; Steinberg A; Popat U; Wingard JR; Mattsson J; Majhail NS
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1777-84. PubMed ID: 25042734
[TBL] [Abstract] [Full Text] [Related]
5. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis.
Wu CH; Sahoo D; Arvanitis C; Bradon N; Dill DL; Felsher DW
PLoS Genet; 2008 Jun; 4(6):e1000090. PubMed ID: 18535662
[TBL] [Abstract] [Full Text] [Related]
6. Splicing factor srp20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma.
Chen W; Itoyama T; Chaganti RS
Genes Chromosomes Cancer; 2001 Nov; 32(3):281-4. PubMed ID: 11579468
[TBL] [Abstract] [Full Text] [Related]
